GE Healthcare Technology | GEHC | Long at $62.25GE Healthcare Technology $NASDAQ:GEHC. An aging and unhealthy population will only create an increased need for healthcare imaging services. Add AI to the diagnostic mix, and imaging will be imperative for routine health maintenance and screening. With a P/E of 15x, debt-to equity of 1x, earnings fo
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.962 CHF
1.81 B CHF
17.87 B CHF
456.62 M
About GE HealthCare Technologies Inc.
Sector
Industry
CEO
Peter J. Arduini
Website
Headquarters
Chicago
Founded
1892
FIGI
BBG01C83JBG5
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Advanced Visualization Solutions segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Double Top Formation on GEHC - Bearish BreakdownGEHC is showing a potential double top around the 94.50 level. A confirmation of the breakdown is expected if the price falls below the confirmation level. This setup suggests a move toward the target of 58.91, with a stop loss placed above the 95.87 level.
Key Levels:
Entry: Below confirmation l
GEHC: Approaching support with potential rebound toward 100GEHC recently began to pull back from 94.55 towards a support zone below 77, with the first major support around 75. If the stock holds above this level, it is highly likely to see a gradual rise toward the 100 and 120 target zones, potentially reaching these levels by June 2025. The stock has signi
GEHC 1H Long Swing Aggressive Trend TradeAggressive Trend Trade
- short impulse
+ volumed T1
+ support level
+ volumed 2Sp-
+ weak test
+ first bullish bar closed entry
Calculated affordable stop limit
1 to 2 R/R take profit
Daily Trend
"+ long impulse
+ T2 level
+ 1/2 correction
+ support level
+ volumed 2Sp-
- independent approach"
Mo
GEHC 1H Swing Long Aggressive Trend TradeAggressive Trend Trade
- short impulse
- unvolumed T1 level
+ biggest volume 2Sp+
+ weak test
+ first bullish bar closed entry
Calculated affordable stop limit
Take profit:
- 60% 1 to 2 R/R
- 40% daily T1
Daily context
"- short impulse
- unvolumed T1 level
+ biggest volume 2Sp+
+ weak test
+ first
GE HealthCare | GEHCGE Healthcare aka GEHC is a renowned global medical technology, pharmaceutical diagnostics, and digital solutions company that aims to revolutionize healthcare by eliminating limits. With a diverse portfolio of innovative products, services, and solutions, GEHC empowers healthcare professionals to m
GEHC topped out in an ascending channel SHORTGEHC is a new spinoff from General Electric. It has great success thus far with good earnings
reports and no dependency on debt and interest rates. It has been on an uptrend since
the November earnings. At present it is correcting. I will play this going short on shares while
hedging with a lon
GE HealthCare Surpasses Expectations with Strong Q4 PerformanceGeneral Electric's healthcare division (NASDAQ: NASDAQ:GEHC ), GE HealthCare, has emerged as a standout performer in the fourth quarter, exceeding both revenue and earnings estimates. Despite ongoing challenges in the global market, the company has demonstrated resilience and delivered robust financ
$GEHC Long term for portfolioNASDAQ:GEHC GE Healthcare has been spun off for over a year now and for as old of a company it is I think there will be room for growth. We are just starting to see the new identity this company will be taking on with the recent acquisition in the AI field.
Compared to its peers its trading at a
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GE5501817
GE Healthcare Technologies Inc. 5.6% 15-NOV-2025Yield to maturity
10.61%
Maturity date
Nov 15, 2025
GE5591354
GE Healthcare Technologies Inc. 6.377% 22-NOV-2052Yield to maturity
6.14%
Maturity date
Nov 22, 2052
US36267VAL7
GE HEALTH.T. 22/24 144AYield to maturity
6.11%
Maturity date
Nov 22, 2052
GE5501821
GE Healthcare Technologies Inc. 6.377% 22-NOV-2052Yield to maturity
5.52%
Maturity date
Nov 22, 2052
GE5501816
GE Healthcare Technologies Inc. 5.6% 15-NOV-2025Yield to maturity
5.47%
Maturity date
Nov 15, 2025
GE5501819
GE Healthcare Technologies Inc. 5.857% 15-MAR-2030Yield to maturity
5.37%
Maturity date
Mar 15, 2030
US36267VAJ2
GE HEALTH.T. 22/32 144AYield to maturity
5.37%
Maturity date
Nov 22, 2032
GE5591353
GE Healthcare Technologies Inc. 5.905% 22-NOV-2032Yield to maturity
5.32%
Maturity date
Nov 22, 2032
GE5501722
GE Healthcare Technologies Inc. 5.905% 22-NOV-2032Yield to maturity
5.21%
Maturity date
Nov 22, 2032
GE5501813
GE Healthcare Technologies Inc. 5.65% 15-NOV-2027Yield to maturity
5.08%
Maturity date
Nov 15, 2027
GE5591352
GE Healthcare Technologies Inc. 5.857% 15-MAR-2030Yield to maturity
5.01%
Maturity date
Mar 15, 2030
See all L0T bonds
Related stocks
Frequently Asked Questions
The current price of L0T is 51.682 CHF — it has decreased by −30.34% in the past 24 hours. Watch GE HEALTHCARE TECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange GE HEALTHCARE TECH stocks are traded under the ticker L0T.
L0T stock has fallen by −30.34% compared to the previous week, the month change is a −30.34% fall, over the last year GE HEALTHCARE TECH has showed a −34.03% decrease.
We've gathered analysts' opinions on GE HEALTHCARE TECH future price: according to them, L0T price has a max estimate of 94.84 CHF and a min estimate of 70.92 CHF. Watch L0T chart and read a more detailed GE HEALTHCARE TECH stock forecast: see what analysts think of GE HEALTHCARE TECH and suggest that you do with its stocks.
L0T stock is 43.56% volatile and has beta coefficient of 1.12. Track GE HEALTHCARE TECH stock price on the chart and check out the list of the most volatile stocks — is GE HEALTHCARE TECH there?
Today GE HEALTHCARE TECH has the market capitalization of 23.28 B, it has decreased by −1.04% over the last week.
Yes, you can track GE HEALTHCARE TECH financials in yearly and quarterly reports right on TradingView.
GE HEALTHCARE TECH is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
L0T earnings for the last quarter are 1.32 CHF per share, whereas the estimation was 1.15 CHF resulting in a 14.78% surprise. The estimated earnings for the next quarter are 0.81 CHF per share. See more details about GE HEALTHCARE TECH earnings.
GE HEALTHCARE TECH revenue for the last quarter amounts to 4.83 B CHF, despite the estimated figure of 4.84 B CHF. In the next quarter, revenue is expected to reach 4.13 B CHF.
L0T net income for the last quarter is 654.81 M CHF, while the quarter before that showed 399.14 M CHF of net income which accounts for 64.06% change. Track more GE HEALTHCARE TECH financial stats to get the full picture.
Yes, L0T dividends are paid quarterly. The last dividend per share was 0.032 CHF. As of today, Dividend Yield (TTM)% is 0.20%. Tracking GE HEALTHCARE TECH dividends might help you take more informed decisions.
GE HEALTHCARE TECH dividend yield was 0.16% in 2024, and payout ratio reached 2.88%. The year before the numbers were 0.16% and 3.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 23, 2025, the company has 53 K employees. See our rating of the largest employees — is GE HEALTHCARE TECH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GE HEALTHCARE TECH EBITDA is 3.15 B CHF, and current EBITDA margin is 17.97%. See more stats in GE HEALTHCARE TECH financial statements.
Like other stocks, L0T shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GE HEALTHCARE TECH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GE HEALTHCARE TECH technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GE HEALTHCARE TECH stock shows the strong sell signal. See more of GE HEALTHCARE TECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.